Aims-To establish whether the multinucleate cells in lesions of patients with cherubism are also osteoclasts and if this is the case whether they were responsive to calcitonin; to carry out cytogenetic studies on two members of the same family affected by cherubism in an attempt to identify any major chromosomal defects; and to perform an in-depth modern biochemical study of four children in the same family. Subjects and methods-Four related children with cherubism were studied. Tissue taken from one of the children at elective decompression of an optic nerve was submitted to in vitro bone resorption studies. Cytogenetic studies were done on two of the children and biochemical studies on all four. Results-The multinucleate cells in the cherubic lesions were shown to be osteoclasts since they synthesised tartrate resistant acid phosphatase, expressed the vitronectin receptor, and resorbed bone. Bone resorption by the cultured multinucleate cells was significantly inhibited by calcitonin. High resolution cytogenetic studies failed to detect any chromosomal abnormalities in two children with cherubism. The biochemistry profile of all four children with cherubism showed that serum calcium, parathyroid hormone, parathyroid related hormone, calcitonin, and alkaline phosphatase were within normal levels. Urine analysis of pyridinium and deoxypyridinium cross links, hydroxyproline, and calcium in relation to urine creatinine were measured to assess bone resorption in these children, and the values were at the upper end ofthe normal range in all four. Conclusions-Further studies are required to determine whether calcitonin treatment will control this grossly deforming disease until the time when the physiological changes that occur at puberty rectify the pathology. It is not recommended that biochemical markers of bone resorption are used in isolation to monitor the activity of cherubism in individuals because the results are based on a small number of children and because of reports of marked interindividual variation in the levels of these markers, particularly in children. (, Clin Pathol 1998;51:831-837) 
Cherubism is a grossly deforming disease of the jaw and is generally inherited as an autosomal dominant trait,' 2 with incomplete penetrance and variable expressivity.' Sporadic cases have also been reported.3`At birth, the jaw of the affected individuals is apparently normal and the disease usually presents between two and five years of age, although there is a report of the diagnosis being made as early as 18 months.6 The disease progresses until puberty, at which time it stabilises and regresses so that by the time the individuals are in their mid-twenties, their facial features are generally not recognised as having been affected by the disease. However, residual deformity of the jaws has been reported.6 7 In a typical case, painless symmetric, multilocular, radiolucent, expansile lesions develop at the angle and vertical ramus of the lower jaw. In more severely affected cases, the lesions ramify through both the upper and lower jaws, with extensive bone loss. This is associated with interference with tooth development, and premature tooth exfoliation may occur. Nonfacial bones are generally not affected, although bifid ribs have been reported. A further unexplained feature of the condition is marked cervical lymphadenopathy.6 8 The histology of this lesion is well described.9 10 It comprises a mononuclear fibroblastic stroma in which large numbers of multinucleate cells are present and there may be cyst formation. Newly formed osteoid or bone is often seen at the periphery of lesional tissue. The histology is virtually identical to that seen in peripheral and central giant cell granulomata of jaw." Giant cell granuloma of the jaw and osteoclastoma are also histologically similar but the former is usually unilateral, whereas cherubism is a symmetric lesion, involving both sides of the jaw. Osteoclastoma rarely occurs at this site. The differential diagnosis of cherubism includes fibrous dysplasia and hyperparathyroidism, as these lesions also contain large numbers of osteoclasts. However, the histological features of fibrous dysplasia differ from those in cherubism in that, in the classical form, Chinese- figure- (fig  2) , and has become more severe than it was in fathers A and B. Subsequent radiological examination of her cousins (child C at 20 months, and child D at two years) showed that they had similar disease. Child B is minimally affected, with radiolucencies only in both vertical rami of the lower jaw and possibly in both maxillary tuberosities. The condition has progressed steadily in children A, C, and D, and all three show marked facial deformities and displacement or loss of teeth (fig 3) . Child A has been treated surgically for severe proptosis of her right eye and child B has had jaw surgery. Children A, C, and D are currently undergoing medical treatment for cherubism.
Methods

IN VITRO BONE RESORPTION STUDIES
Elective decompression of the right optic nerve was undertaken on the eldest of the four children (child A). Tissue was taken at the time of surgery and fixed in formalin for histological examination, "dabbed" onto glass slides for immunohistochemistry, and a small amount of fresh tissue placed in phosphate buffered saline (PBS) for tissue culture studies. The latter was transported to the laboratory on ice, where it was minced into tiny explants and sedimented onto wafers of devitalised bovine bone (3 x 3 x 0.1 mm), as described previously,'6 in a 24 well plate (Sterilin) containing Medium 199 with penicillin/streptomycin and glutamine (all from Gibco Life Technologies). After 45 minutes the bone slices were washed vigorously and placed in a 96 well plate in minimum essential medium with Hanks' salts (Gibco Life Technologies), with 0.1% bovine serum albumin (Sigma), L-glutamine, 100 IU benzyl penicillin/ml (Gibco Life Technologies), and 100 ,ug streptomycin/ml (Gibco), and incubated at 37°C in a humidified atmosphere of 5% CO2/95% air. Salmon calcitonin (sCT) (kindly provided by Rhone-Poulenc Rorer, Pennsylvania, USA) was added to the cultures at final concentrations of 0.1 pg/ml to 10 ng/ml. After 18 hours the bone slices were washed in PBS, fixed in formalin, and stained in 0.1% toluidine blue (Sigma) for five minutes. The area of bone resorption on the bone slices was quantified using reflected light and an image analysis system (Seescan). Bone resorption was expressed as the total (mean) plan area (SEM) of resorption per bone slice. Statistical significance was determined by Student's t test.
The cells were later removed from the bone surfaces by immersing the cells in sodium hypochlorite for five minutes. They were then sputter coated with gold and the bone slices in their entirety were scanned for bone resorption Cells were also sedimented onto bone slices to stain them for tartrate resistant acid phosphatase. Staining for tartrate resistant acid phosphatase and the a,3, subunit of the vitronectin receptor using monoclonal antibody 23c6,'7 18 was carried out using conventional techniques. The substrate used for the former was alkaline phosphatase and for the latter, naphthol AS-B 1 phosphate. Tartrate resistance was assessed in the presence of 0.05 M sodium tartrate. The cultures were counterstained with toluidine blue.
CYTOGENETIC STUDIES
Venous blood (10 ml) was taken from two siblings who are severely affected by cherubism. High resolution cytogenetic studies were carried out by conventional techniques on these samples. " Figure 2 Child A at 4, 8, 9, and 13 years of age (A-D). The features of cherubism are most severe at the age of 13. At 4 years of age, the child would be considered normal if the photograph were examined in isolation, but when studied in sequence it is clear that the early stages of cherubism are present and that there is slight puffiness of the cheeks. To preserve anonymity the eyes are obscured and the severe proptosis is not seen.
--..... Urine from all four children showed high fasting calcium to creatinine ratios compared with published reference ranges.24 25 However, e slice after 18 reduced cell motility and a dramatic shape change, and that these morphological changes are reversed when the calcitonin is removed from the medium.26 This suggests that calcitonin inhibits bone resorption by inducing a quiescent state in osteoclasts and not by reducing osteoclast numbers.
It is thought that osteoblasts play a central role in osteoclast recruitment, formation, and resorption,27 28 and it has been proposed that osteoclast-rich lesions-including the osteoclastoma, central and peripheral granulomas of the jaw, and osteoclast-rich malignant fibrous histiocytoma-contain a cell of the osteoblast lineage which is responsible for the recruitment of the osteoclast or its precursor into these lesions.'3 14 with cherubism would require treatment for several years.
Documentation of the biochemistry in the aggressive form of cherubism is limited. Serum calcium has generally been reported as normal and we confirmed this in the current study. This is not unexpected in view of the localised site of the disease and it is consistent with the report from Davis et al, who found that serum calcium and PTH concentrations were within the normal range in a patient with multifocal osteoclastic lesions.34 However, in contrast to our findings in cherubism, this individual had high levels of PTH-rP, alkaline phosphatase (not separate components), and serum calcitonin. Urine analysis was not performed in this study.
The urine hydroxyproline to creatinine ratio is largely a reflection of total collagen in the fasting state: it is not specific for bone collagen and furthermore it is known to be significantly higher in growing children than in adults. 22 We also measured bone turnover using the fluorescent assay for total pyridinium and deoxypyridinium cross links (which are newer and more specific markers of bone turnover, the latter being more specific for bone collagen35). The concentrations of these markers were repeatedly at the upper end of the reference data of Rausch et al,23 and it is interesting to speculate that they may reflect the activity of the localised bone disease in these children. However, it is well documented that there is marked day to day interindividual variation, especially in children, in the levels of urinary pyridinium and deoxypyridinium cross links. Hence we do not recommend that this assay is used in isolation as a means of monitoring children with cherubism, particularly since our data are derived from a small number of patients.
Identification of the genetic mutation which is responsible for cherubism would have widespread implications in terms of understanding the biology of the osteoclast. The osteoclast is a rare cell in the human body and its poor availability makes study of its biology difficult. Studies which have had the greatest impact on our understanding of the biology of the osteoclast have come from recent molecular investigations of natural and genetically engineered mutations in mice.3$35
Cherubism, as one of the very few genetically determined osteoclastic lesions in the human body, is an ideal disease for the study of osteoclast biology and pathology.
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